08.12.2023 15:42:25

Veradigm CEO, CFO To Leave As Investigation Is On Regarding Co's Financial Reporting; Stock Down

(RTTNews) - Veradigm Inc. (MDRX), a healthcare technology company, on Friday said the Board has asked its Chief Executive Officer Richard Poulton, and Chief Financial Officer Leah Jones to resign following Audit Committee's independent investigation about its financial reporting and possible impacts on its previous reports.

Previously, the healthcare company had received a notice from Nasdaq indicating that it was non-compliant with Nasdaq Listing Rule as it failed to file annual report for the year ended December 31, 2022, quarterly report for the period ended March 31, 2023 among others.

The current chairman Greg Garrison has been appointed as the executive chairman and present director Shih-Yin Ho, has been named the interim chief executive officer of the company.

Additionally, Lee Westerfield who has more than 25 years of experience and is the current finance chief at Clearsense will serve as the interim chief financial officer.

The company has initiated a search for a permanent CEO and CFO.

Meanwhile the new leadership team is reviewing the financial guidance for fiscal 2023 issued on September 18.

Currently, Veradigm shares are trading at $10.81 down 14.10% on the Nasdaq.

Nachrichten zu Allscripts Healthcare Solutions Incmehr Nachrichten

26.09.24
NASDAQ Composite Index-Titel Allscripts Healthcare Solutions-Aktie: So viel hätte eine Investition in Allscripts Healthcare Solutions von vor einem Jahr gekostet (finanzen.at)
19.09.24
NASDAQ Composite Index-Papier Allscripts Healthcare Solutions-Aktie: So viel Verlust wäre bei einem Investment in Allscripts Healthcare Solutions von vor 10 Jahren angefallen (finanzen.at)
12.09.24
NASDAQ Composite Index-Titel Allscripts Healthcare Solutions-Aktie: So viel hätten Anleger mit einem Investment in Allscripts Healthcare Solutions von vor 5 Jahren verloren (finanzen.at)
05.09.24
NASDAQ Composite Index-Papier Allscripts Healthcare Solutions-Aktie: So viel hätten Anleger an einem Allscripts Healthcare Solutions-Investment von vor 3 Jahren verloren (finanzen.at)
29.08.24
NASDAQ Composite Index-Papier Allscripts Healthcare Solutions-Aktie: So viel Verlust hätte eine Allscripts Healthcare Solutions-Investition von vor einem Jahr eingebracht (finanzen.at)
22.08.24
NASDAQ Composite Index-Wert Allscripts Healthcare Solutions-Aktie: So viel hätte eine Investition in Allscripts Healthcare Solutions von vor 10 Jahren gekostet (finanzen.at)
15.08.24
NASDAQ Composite Index-Wert Allscripts Healthcare Solutions-Aktie: So viel hätten Anleger an einem Allscripts Healthcare Solutions-Investment von vor 5 Jahren verdient (finanzen.at)
08.08.24
NASDAQ Composite Index-Titel Allscripts Healthcare Solutions-Aktie: So viel Verlust hätte ein Investment in Allscripts Healthcare Solutions von vor 3 Jahren eingebracht (finanzen.at)

Analysen zu Allscripts Healthcare Solutions Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Allscripts Healthcare Solutions Inc 9,20 4,55% Allscripts Healthcare Solutions Inc